{"SPADE_N_06541": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06541", "Peptide Name": "LR-13", "Source": "AMP", "Family": "", "Gene": "Not found", "Sequence": "CLLRRLLRRLLRR", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HCT 116 (IC50=15.6±1.0 µM); HeLa (IC50=26.7±1.3 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HDF:IC50=24±5 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C75H145N31O14S", "Mass": 1737.22, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -0.13, "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Rationally designed short cationic α-helical peptides with selective anticancer activity", "Pubmed ID": "34509120", "Reference": "J Colloid Interface Sci. 2022 Feb;607(Pt 1)488-501.", "Author": "Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34509120"}], "Frequent Amino Acids": "LRC", "Absent Amino Acids": "ADEFGHIKMNOPQSTUVWY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 7, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18794", "Similarity": 1.0, "Sequence": "GLRCLRLRGRLRLGRCLLR"}, {"SPADE_ID": "SPADE_UN_22527", "Similarity": 1.0, "Sequence": "LLVLRSLGPWHPGHCLLR"}, {"SPADE_ID": "SPADE_UN_24839", "Similarity": 1.0, "Sequence": "CLLRRLLRRLLRR"}]}}}